Bio-Rad Labs (BIO) Tops Q2 EPS by 32c
Tweet
Share
E-mail
Get Alerts BIO Hot Sheet
Price: $380.68 +0.44%
EPS Growth %: -1.3%
Financial Fact:
Foreign exchange losses, net: 1.24M
Today's EPS Names:
ALZN, ASPU, USAU, More
EPS Growth %: -1.3%
Financial Fact:
Foreign exchange losses, net: 1.24M
Today's EPS Names:
ALZN, ASPU, USAU, More
Join SI Premium – FREE
Bio-Rad Labs (NYSE: BIO) reported Q2 EPS of $3.00, $0.32 better than the analyst estimate of $2.68. Revenue for the quarter came in at $681.1 million versus the consensus estimate of $697.96 million.
For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UBS sees a negative catalyst ahead for Nike: Here’s what to watch
- Astrana Health (ASTH) Mentioned as short at Glass House
- Bio-Rad to Participate in Fireside Chat During Bernstein Insights Healthcare Leaders and Disruptors 3rd Annual Forum
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
